Novo Nordisk Pharmatech has entered into an agreement with Helm de México, which will be responsible for the distribution of Novo's Quats (synthetic molecules) in Mexico.
"We are very excited to announce the new distribution agreement between Helm de México and Novo Nordisk Pharmatech. We believe it is a mutually beneficial agreement. On the one hand, Novo Nordisk Pharmatech will gain access to Helm's extensive network of customers in the pharmaceutical/cosmetics industry along with the distribution infrastructure HELM has built in the 55 years we have been present in the Mexican market," Boy Ehlers, Managing Director of Helm de México, says in a Novo Nordisk Pharmatech press release, adding:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Regulatory Project Manager 
eTMF Manager 
CMC Writer 
Vice President, Medical Affairs 
Process Supporter working with SAP 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Senior CMC Regulatory Manager 
Sales Manager Denmark 
Clinical Project Lead 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Manager of QA, BHS Logistics 
Chief Business Officer 
Product specialist 
Scientist Radiochemistry 
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Senior/lead consultant at Emendo Engineering 
Lab Manager